Brain membrane cholesterol domains, aging and amyloid beta-peptides

Neurobiology of Aging

Volumn 23, Issue 5, 2002, Pages 685-694

  Wood, W Gibson ^a   Schroeder, Friedhelm ^b   Igbavboa, Urule ^a   Avdulov, Nicolai A ^a   Chochina, Svetlana V ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Aging; Alzheimer's disease; Amyloid beta peptides; Annular lipids; Caveolae; Caveolin; Cholesterol; Fatty acid binding proteins; Lipid domains; Lipid rafts; Neurons; Sterol carrier protein 2

Indexed keywords

AMYLOID BETA PROTEIN; CHOLESTEROL; MEMBRANE LIPID;

AGING; ARTICLE; BRAIN MEMBRANE; CELL GROWTH; CELL MEMBRANE; HUMAN; LIPID METABOLISM; LIPID TRANSPORT; MOLECULAR INTERACTION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN INTERACTION; SENILE PLAQUE; SIGNAL TRANSDUCTION;

AGED; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CELL MEMBRANE; CHOLESTEROL; HUMANS;

EID: 0036752025     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00018-0     Document Type: Article

References (115)

1. Agranoff BW. In: Siegel G, Agranoff BW, Albers RW, Molinoff P, editors. Lipids in basic neurochemistry: molecular, cellular, and medical aspects. New York: Raven Press, 1989.
2. Anderson R.G.W. Caveolae: where incoming and outgoing messengers meet. Proc. Natl. Acad. Sci. USA. 90:1993;10909-10913.
3. Avdulov N.A., Chochina S.V., Draski L., Deitrich R.A., Wood W.G. Chronic ethanol consumption alters effects of ethanol in vitro on brain membrane structure of HAS and LAS rats. Alcohol Clin. Exp. Res. 19:1995;886-891.
4. Avdulov N.A., Chochina S.V., Igbavboa U., O'Hare E.O., Schroeder F., Cleary J.P.et al. Amyloid β-peptides increase annular and bulk fluidity and induce lipid peroxidation in brain synaptic plasma membranes. J. Neurochem. 68:1997;2086-2091.
5. Avdulov N.A., Chochina S.V., Igbavboa U., Vassiliev A.V., Wood W.G. Lipid binding to amyloid β-peptide: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids. J. Neurochem. 69:1997;1746-1752.
6. Avdulov N.A., Chochina S.V., Igbavboa U., Warden C., Schroeder F., Wood W.G. Lipid binding to sterol carrier protein-2 is inhibited by ethanol. Biochim. Biophys. Acta. 1437:1999;37-45.
7. Avdulov N.A., Wood W.G., Harris R.A. Effects of ethanol on structural parameters of rat brain membranes: relationship to genetic differences in ethanol sensitivity. Alcohol Clin. Exp. Res. 18:1994;53-59.
8. Bakircioglu M.E., Sievert K.D., Nunes L., Lau A., Lin C.S., Lue T.F. Decreased trabecular smooth muscle and caveolin-1 expression in the penile tissue of aged rats. J. Urol. 166:2001;734-738.
9. Bevers E.M., Comfurius P., Dekkers D.W.C., Zwaal R.F.A. Lipid translocation across the plasma membrane of mammalian cells. Biochim. Biophys. Acta. 1439:1999;317-330.
10. Bodovitz S., Klein W.L. Cholesterol modulates α-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271:1996;4436-4440.
11. Bouillot C., Prochiantz A., Rougon G., Allinquant B. Axonal amyloid precursor protein expressed by neurons in vitro is present in a membrane fraction with caveolae-like properties. J. Biol. Chem. 271:1996;7640-7644.
12. Brown D.A., London E. Structure and function of sphingolipid-and cholesterol-rich membrane rafts. J. Biol. Chem. 275:2000;17221-17224.
13. Cameron P.L., Ruffin J.W., Bollag R., Rasmussen H., Cameron R.S. Identification of caveolin and caveolin-related proteins in the brain. J. Neurosci. 17:1997;9520-9535.
14. 1-40 increases neuronal membrane fluidity: role of cholesterol and brain region. J. Lipid Res. 42:2001;1292-1297.
15. Choo-Smith L.P., Garzon-Rodriguez W., Glabe C.G., Surewicz W.K. Acceleration of amyloid fibril formation by specific binding of Aβ-(1-40) peptide to ganglioside-containing membrane vesicles. J. Biol. Chem. 272:1997;22987-22990.
16. Degraeve F., Bolla M., Blaie S., Creminon C., Quere I., Boquet P.et al. Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins. J. Biol. Chem. 276:2001;46849-46855.
17. Eckert G.P., Cairns N.J., Maras A., Gattaz W.F., Müller W.E. Cholesterol modulates the membrane disordering effects of β-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 11:2000;181-186.
18. Eckert G.P., Kirsch C., Müller W.E. Differential effects of lovastatin treatment on brain cholesterol levels in normal and apoE deficient mice. Neuroreport. 12:2001;883-887.
19. Farooqui A.A., Rapoport S.I., Horrocks L.A. Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens. Neurchem. Int. 22:1997;523-527.
20. Fassbender K., Simons M., Bergmann C., Stroick M., Lutjohann D., Keller P.et al. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. PNAS. 98:2001;5856-5861.
21. Fernandez-Ballester G., Castresana J., Fernandez A.M., Arrondo J.-L.R., Ferragut J.A., Gonzalez-Ros J.M. A role for cholesterol as a structural effector of the nicotinic acetylcholine receptor. Biochemistry. 33:1994;4065-4071.
22. Fontaine R.N., Harris R.A., Schroeder F. Aminophospholipid asymmetry in murine synaptosomal plasma membrane. J. Neurochem. 34:1980;269-277.
23. Galbiati F., Engelman J.A., Volonte D., Zhang X.L., Minetti C., Li M.et al. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities. J. Biol. Chem. 276:2001;21425-21433.
24. Galbiati F., Volonte D., Gil O., Zanazzi G., Salzer J.L., Sargiacomo M.et al. Expression of caveolin-1 and -2α in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. PNAS. 95:1998;10257-10262.
25. Hayashi H., Mizuno T., Michikawa M., Haass C., Yanagisawa K. Amyloid precursor protein in unique cholesterol-rich microdomains different from caveolae-like domains. Biochim. Biophys. Acta. 1483:2000;81-90.
26. Henderson L.P., Lin L., Prasad A., Paul C.A., Chang T.Y., Maue R.A. Embryonic striatal neurons from Niemann-Pick Type C mice exhibit defects in cholesterol metabolism and neurotrophin responsiveness. J. Biol. Chem. 275:2001;20179-20187.
27. Hooper N.M. Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae. Mol. Mem. Biol. 16:1999;145-156 [Review].
28. Howlands D.S., Trusko S.P., Savage M.J., Reaume A.G., Lang D.M., Hirsch J.D.et al. Modulation of secreted beta-amyloid precursor protein and amyloid beta peptide in brain by cholesterol. J. Biol. Chem. 273:1998;16576-16582.
29. Igbavboa U., Avdulov N.A., Chochina S.V., Wood W.G. Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low density lipoprotein receptor, apolipoprotein E, or both proteins. J. Neurochem. 69:1997;1661-1667.
30. Igbavboa U., Avdulov N.A., Schroeder F., Wood W.G. Increasing age alters transbilayer fluidity and cholesterol asymmetry in synaptic plasma membranes of mice. J. Neurochem. 66:1996;1717-1725.
31. Igbavboa U, Hamilton J, Kim H-Y, Sun GY, Wood WG. A new role for apolipoprotein E: modulating transport of polyunsaturated phospholipid molecular species in synaptic plasma membranes. J Neurochem 2002;80:255-61.
32. Jick H., Zornberg G.L., Jick S.S., Seshadri S., Drachman D.A. Statins and the risk of dementia. Lancet. 356:2000;1627-1631.
33. Jones O.T., McNamee M.G. Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor. Biochemistry. 27:1988;2364-2374.
34. Jost P.C., Griffith O.H. Lipid-lipid and lipid-protein interactions in membranes. Pharm. Biochem. Behav. 13:1980;155-165.
35. Jost P.C., Griffith O.H., Capaldi R.A., Vanderkooi G. Evidence for boundary lipid in membranes. Proc. Natl. Acad. Sci. USA. 70:1973;480-484.
36. Kakio A., Nishimoto S.-I., Yanagisawa K., Kozutsumi Y., Matsuzaki K. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 276:2001;24985-24990.
37. Kojro E., Gimpl G., Lammich S., Marz W., Fahrenholz F. From the Cover: low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc. Natl. Acad. Sci. USA. 98:2001;5815-5820.
38. Koudinov A.R., Koudinova N.V. Esstential role for cholesterol in synaptic plasticity and neuronal degeneration. FASEB J. 15:2001;1858-1860.
39. Lee AG. Annular lipids and the activity of the calcium-dependent ATPase. In: Aloia RC, Curtain CC, Gordon LM, editors. Lipid domains and the relationship to membrane function. New York: Alan R. Liss Inc., 1988.
40. Lee S.-J., Liyanage U., Bickel P.E., Xia W., Lansbury P.T., Kosik K.S. A detergent-insoluble membrane compartment contains amyloid-beta in vivo. Nature Medicine. 4:1998;730-734.
41. Lentz BR. Organization of membrane lipids by intrinsic membrane proteins. In: Aloia RC, Curtain CC, Gordon LM, editors. Lipid domains and the relationship to membrane function. New York: Alan R. Liss Inc., 1988.
42. Lisanti M.P., Scherer P.E., Tang Z., Sargiacomo M. Caveolae, caveolin and caveolin-rich membrane domains: a signaling hypothesis. Trends Cell Biol. 4:1994;231-235.
43. Liu Y. Understanding the biological activity of amyloid proteins in vitro: from inhibited cellular MTT reduction to altered cellular cholesterol homeostasis. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 23:1999;377-395.
44. Low M.G. The glycosyl-phosphatidylinositol anchor of membrane proteins. Biochim. Biophys. Acta. 988:1989;427-454.
45. Maekawa S., Sato C., Kitajima K., Funatsu N., Kumanogoh H., Sokawa Y. Cholesterol-dependent localization of NAP-22 on a neuronal membrane microdomain (raft). J. Biol. Chem. 274:1999;21369-21374.
46. Marsh D., Barrantes F.J. Immobilized lipid in acetylcholine receptor-rich membranes from Torpedo marmorata. Proc. Natl. Acad. Sci. USA. 75:1978;4329-4333.
47. Marsh D, Watts A. Association of lipids with membrane proteins. In: Aloia RC, Curtain CC, Gordon LM, editors. Lipid domains and the relationship to membrane function. New York: Alan R. Liss Inc., 1988.
48. Martens J.R., Navarro-Polanco R., Coppock E.A., Nishiyama A., Parshley L., Grobaski T.D. Differential targeting of shaker-like potassium channels to lipid rafts. J. Biol. Chem. 275:2000;7443-7446.
49. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I., Roses A.D. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136:1995;107-122.
50. Masliah E., Mallory M., Veinbergs I., Miller A., Samuel W. Alternations in apolipoprotein E expression during aging and neurodegeneration. Prog. Neurobiol. 50:1996;493-503.
51. Mason R.P., Jacob R.F., Walter M.F., Mason P.E., Avdulov N.A., Chochina S.V.et al. Distribution and fluidizing action of soluble and aggregated amyloid beta-peptide in rat synaptic plasma membranes. J. Biol. Chem. 274:1999;18801-18807.
52. Matsuzaki K., Horikiri C. Interactions of amyloid β-peptide (1-40) with ganglioside-containing membranes. Biochemistry. 38:1999;4137-4142.
53. Mauch D.H., Nägler K., Schumacher S., Göritz C., Müller E.-C., Otto A.et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 294:2001;1354-1357.
54. McLaurin J., Chakrabartty A. Characterization of the interactions of Alzheimer β-amyloid peptides with phospholipid membranes. Eur. J. Biochem. 245:1997;355-363.
55. McLean L., Phillips M.C. Mechanism of cholesterol and phosphatidylcholine exchange of transfer between unilamellar vesicles. Biochemistry. 20:1981;2893-2900.
56. Mizuno T., Haass C., Michikawa M., Yanagisawa K. Cholesterol-dependent generation of a unique amyloid β-protein from apically missorted amyloid precursor protein in MDCK cells. Biochim. Biophys. Acta. 1373:1998;119-130.
57. Mizuno T., Nakata M., Naiki H., Michikawa M., Wang R., Haass C.et al. Cholesterol-dependent generation of a seedling amyloid β-protein in cell culture. J. Biol. Chem. 274:1999;15110-15114.
58. sw mice. J. Neuropathol. Exp. Neurol. 60:2001;778-785.
59. Morishima-Kawashima M., Ihara Y. The presence of amyloid β-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells. Biochemistry. 37:1998;15247-15253.
60. Mukherjee S., Zha X., Tabas I., Maxfield F.R. Cholesterol distribution in living cells: fluorescence imaging using dehydroergosterol as a fluorescent cholesterol analog. Biophys. J. 75:1998;1915-1925.
61. Myers-Payne S.C., Fontaine R.N., Loeffler A., Pu L., Rao A.M., Kier A.B.et al. Effects of chronic ethanol consumption on sterol transfer proteins in mouse brain. J. Neurochem. 66:1996;313-320.
62. Nemecz G., Fontaine R.N., Schroeder F. A fluorescence and radiolabel study of sterol exchange between membranes. Biochim. Biophys. Acta. 943:1988;511-521.
63. Nishiyama K., Trapp B.D., Ikezu T., Ransohoff R.M., Tomita T., Iwatsubo T.et al. Caveolin-3 upregulation activates β-secretase-mediated cleavage of the amyloid precursor protein in Alzheimer's disease. J. Neurosci. 19:1999;6538-6548.
64. Orsó E., Broccardo C., Kaminski W.E., Bottcher A., Liebisch G., Drobnik W.et al. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and ABC1-deficient mice. Nature Genet. 24:2000;192-196.
65. Oshima N., Morishima-Kawashima M., Yamaguchi H., Yoshimura M., Sugihara S., Khan K.et al. Accumulation of amyloid β-protein in the low-density membrane domain accurately reflects the extent of β-amyloid deposition in the brain. Am. J. Pathol. 158:2001;2209-2218.
66. Palade G.E. Fine structure of blood capillaries. J. Appl. Phys. 24:1953;1424.
67. Pierini L.M., Maxfield F.R. Flotillas of lipid rafts fore and aft. PNAS. 98:2001;9471-9473.
68. Pitas R.E., Boyles J.K., Lee S.H., Hui D., Weisgraber K.H. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E (LDL) receptors in the brain. J. Biol. Chem. 262:1987;14352-14360.
69. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17:1994;525-530.
70. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 342:1993;697-699.
71. Prasad M.R., Lovell M.A., Yatin M., Dhillon H., Markesbery W.R. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 23:1998;81-88.
72. Pu L., Annan R.S., Carr S.A., Frolov A.A., Wood W.G., Spener F.et al. Isolation and identification of a mouse brain protein recognized by antisera to heart fatty acid-binding protein. Lipids. 34:1999;363-373.
73. Pu L., Igbavboa U., Wood W.G., Roths J.B., Kier A.B., Spener F.et al. Expression of fatty acid binding proteins is altered in aged mouse brain. Mol. Cell Biochem. 198:1998;69-78.
74. Rao A.M., Igbavboa U., Semotuk M., Schroeder F., Wood W.G. Kinetics and size of cholesterol lateral domains in synaptosomal membranes: modification by sphingomyelinase and effects on membrane enzyme activity. Neurochem. Int. 23:1993;45-52.
75. Refolo L.M., Pappolla M.A., Malester B., LaFrancois J., Bryant-Thomas T., Wang R.et al. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Disease. 7:2000;321-331.
76. Rietveld A., Simons K. The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochim Biophys. Acta. 1376:1998;467-479.
77. Ross S.L., Martin F., Simonet L., Jacobsen F., Deshpande R., Vassar R.et al. Amyloid precursor protein processing in sterol regulatory element-binding protein site 2 protease-deficient Chinese hamster ovary cells. J. Biol. Chem. 273:1998;15309-15312.
78. Rubins J.B., Greatens T., Tan A.T., Polunovsky V.A., Bitterman P. Lovastatin induces apoptosis in malignant mesothelioma cells. Am. J. Respir. Crit. Care Med. 157:1998;616-622.
79. Samuel B.U., Mohandas N., Harrison T., McManus H., Rosse W., Reid M.et al. The role of cholesterol and glycosylphosphatidylinositol-anchored proteins of erythrocyte rafts in regulating raft protein content and malarial infection. J. Biol. Chem. 276:2001;29319-29329.
80. Saunders A.M., Strittmatter W.J., Schmechel D., St. George-Hyslop P.H., Pericak-Vance M.A., Joo S.H.et al. Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
81. Schroeder F. Role of membrane lipid asymmetry in aging. Neurobiol. Aging. 5:1984;323-333.
82. Schroeder F. Fluorescence probes unravel asymmetric structure of membranes. Subcellular Biochem. 11:1985;51-100.
83. Schroeder F., Jefferson J.R., Kier A.B., Knittel J., Scallen T.J., Wood W.G.et al. Membrane cholesterol dynamics: cholesterol domains and kinetic pools. Proc. Soc. Exp. Biol. Med. 196:1991;235-252.
84. Schroeder F., Morrison W.J., Gorka C., Wood W.G. Transbilayer effects of ethanol on fluidity of brain membrane leaflets. Biochim. Biophys. Acta. 946:1988;85-94.
85. Schroeder F, Wood WG, Kier AB. Lipid domains and biological membrane function. In: Sperelakis N, editor. Cell physiology sourcebook, a molecular approach. San Diego, CA: Academic Press, 2001.
86. Schroeder F, Wood WG, Morrison WJ, Fontaine RN, Kier AB. Synaptosomal plasma membrane lipid and structural asymmetry. In: Freysz L, Hawthorne JN, Toffano G, editors. Neurochemical aspects of phospholipid metabolism. Padova, Italy: Liviana Press, 1989.
87. Seigneuret M., Zachowski A., Hermann A., Devaux P.F. Asymmetric lipid fluidity in human erythrocyte ghosts: new spin label evidence. Biochemistry. 23:1984;4271-4275.
88. Selkoe D.J. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10:1994;373-403.
89. Simons K., Ikonen E. Functional rafts in cell membranes. Nature. 387:1997;569-572.
90. Simons K., Ikonen E. How cells handle cholesterol. Science. 290:2000;1721-1726.
91. Simons M., Keller P., Destrooper B., Beyreuther K., Dotti C.G., Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. USA. 95:1998;6460-6464.
92. Slotte J.P., Bierman E.L. Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. Biochem. J. 250:1988;653-658.
93. Sparks DL. Coronary artery disease, hypertension, apoE, and cholesterol: a link to Alzheimer's disease? Ann NY Acad Sci 1997;826:128-46.
94. Supernovich C., Crain R., Rosenberg P. Phosphatidylcholine asymmetry in electroplax from the electric eel: use of a phosphatidylcholine exchange protein. J. Neurochem. 57:1991;575-584.
95. Sweet W.D., Schroeder F. Charged anesthetics alter LM fibroblast plasma membrane enzymes by selective fluidization of inner or outer membrane leaflets. Biochem. J. 239:1986;301-310.
96. Sweet WD, Schroeder F. Lipid domains and enzyme activity. In: Aloia RC, Curtain CC, Gordon LM, editors. Lipid domains and the relationship to membrane function. New York: Alan R. Liss Inc., 1988.
97. Sweet W.D., Schroeder F. Polyunsaturated fatty acids alter sterol transbilayer domains in LM fibroblast plasma membranes. FEBS Lett. 229:1988;188-192.
98. Sweet W.D., Wood W.G., Schroeder F. Charged anesthetics selectively alter plasma membrane order. Biochemistry. 26:1987;2828-2835.
99. Vance J.E., Pan D., Campenot R.B., Bussiere M., Vance D.E. Evidence that the major membrane lipids, except cholesterol, are made in axons of cultured rat sympathetic neurons. J. Neurochem. 62:1994;329-337.
100. Weisgraber K.H., Mahley R.W. Human apolipoprotein E: the Alzheimer's disease connection. FASEB J. 10:1996;1485-1494.
101. Wolozin B., Kellman W., Ruosseau P., Celesia G.G., Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57:2000;1439-1443.
102. Wolozin B. A fluid connection: cholesterol and Abeta. PNAS. 98:2001;5371-5373.
103. Wood W.G., Cornwell M., Williamson L.S. High performance thin-layer chromatography and densitometry of synaptic plasma membrane lipids. J. Lipid Res. 30:1989;775-779.
104. Wood W.G., Gorka C., Johnson J.A., Sun G.Y., Sun A.Y., Schroeder F. Chronic ethanol consumption alters transbilayer distribution of phosphatidylcholine in erythrocytes of Sinclair (S-1) miniature swine. Alcohol. 8:1991;395-399.
105. Wood W.G., Gorka C., Schroeder F. Acute and chronic effects of ethanol on transbilayer membrane domains. J. Neurochem. 52:1989;1925-1930.
106. 2+-ATPase activity, interdigitation, and increases fluidity of brain synaptic plasma membranes. Brain Res. 683:1995;36-42.
107. Wood W.G., Rao A.M., Igbavboa U., Semotuk M. Cholesterol exchange and lateral cholesterol pools in synaptosomal membranes of pair-fed control and chronic ethanol-treated mice. Alcohol Clin. Exp. Res. 17:1993;345-350.
108. Wood W.G., Schroeder F., Avdulov N.A., Chochina S.V., Igbavboa U. Recent advances in brain cholesterol dynamics: transport, domains and Alzheimer's disease. Lipids. 34:1999;225-234.
109. Wood W.G., Schroeder F., Hogy L., Rao A.M., Nemecz G. Asymmetric distribution of a fluorescent sterol in synaptic plasma membranes: effects of chronic ethanol consumption. Biochim. Biophys. Acta. 1025:1990;243-246.
110. Wood WG, Schroeder F, Rao AM, Igbavboa U, Avdulov NA. Membranes and ethanol: lipid domains and lipid-protein interactions. In: Deitrich RA, Erwin VG, editors. Pharmacological effects of ethanol on the nervous system. Boca Raton, FL: CRC Press, 1996.
111. Yamada E. The fine structure of the gall bladder epithelium of the mouse. J. Biophys. Biochem. Cytol. 1:1955;445-458.
112. Yanagisawa K., Odaka A., Suzuki N., Ihara Y. GM1 ganglioside-bound amyloid β-protein (Aβ): a possible form of preamyloid in Alzheimer's disease. Nature Medicine. 1:1995;1062-1066.
113. Yeagle P.L. Lipid regulation of cell membrane structure and function. FASEB J. 3:1989;1833-1842.
114. Yip C.M., Elton E.A., Darabie A.A., Morrison M.R., McLaurin J. Cholesterol, a modulator of membrane-associated Aβ-fibrillogenesis and neurotoxicity. J. Mol. Biol. 311:2001;723-734.
115. Zachowski A., Gaudry-Talarmain Y.M. Phospholipid transverse diffusion in synaptosomes: evidence for the involvement of the aminophospholipid translocase. J. Neurochem. 55(4):1990;1352-1356.